JemsMEDIRADAR
Priority Axis 3: Accessible and resilient health services
Operation start date: 15 July 2026
Operation completion date: 14 July 2028
Budget: EUR 1.647.962,58
Number of partners: 2
Operation purpose and expected achievements:
The MEDIRADAR project aims to improve the early detection and diagnosis of breast and mediastinal cancers in Croatia and Bosnia and Herzegovina by strengthening the diagnostic capacities of healthcare institutions and introducing innovative digital pathology and artificial intelligence-based diagnostic solutions. The project addresses common cross-border challenges related to delayed cancer diagnosis, limited access to advanced diagnostic technologies, shortages of specialised medical personnel, and the lack of harmonised diagnostic protocols. Planned activities include the procurement of state-of-the-art medical and digital pathology equipment, the implementation of AI-supported diagnostic tools, the organisation of joint professional training programmes and study visits, the development of harmonised diagnostic workflows and teleconsultation procedures, and the implementation of preventive and awareness-raising activities promoting early cancer detection. Through investments in innovative technologies, professional capacity building, digital transformation, and cross-border knowledge exchange, the project will strengthen the resilience of healthcare systems, improve diagnostic accuracy and efficiency, enhance cooperation between partner institutions, and contribute to earlier diagnosis and better treatment outcomes for cancer patients across the Programme area.
Beneficiaries:
The Lead Partner (LP), Cantonal Hospital “Dr. Safet Mujić” Mostar (BA), is responsible for the overall coordination and management of the project. It oversees project implementation, financial and administrative management, partner coordination, reporting, and quality assurance. The Hospital leads the modernisation of cancer diagnostics through the procurement of advanced diagnostic equipment, including an endobronchial ultrasound (EBUS) system and molecular diagnostic technologies, coordinates the implementation of AI-supported diagnostic solutions and joint teleconsultation models, and ensures the long-term sustainability and transferability of project results across the Programme area.
General Hospital Dubrovnik (HR) provides specialised clinical expertise in pathology and oncology diagnostics and is responsible for implementing the digital transformation of pathology services. The Hospital procures and deploys a digital pathology system, AI-supported pathology software, laboratory information systems, and related digital infrastructure, participates in the development of harmonised diagnostic protocols and teleconsultation procedures, organises joint professional training and study visits with the Lead Partner, and contributes to strengthening cross-border cooperation, knowledge transfer, and the long-term implementation of innovative cancer diagnostic services across the Programme area.